Financial Ratios ORIX Corporation NYSE

Stocks

IX

US6863301015

Diversified Investment Services

Market Closed - NYSE 16:00:02 2026-08-17 EDT			5-day change	1st Jan Change
40.13 ^USD	-0.07%		+0.10%	+37.34%

08-12	Australia's FleetPartners opens books to SG Fleet, Element and ORIX as takeover war heats up	RE
08-11	FleetPartners powers to 8-1/2-year high as ORIX, SG Fleet dial up takeover race	RE

2a11198b0eb97.zMvWOucSwGQubYpVZxThfD7TNtDaT5QkA0v3XLCIH7o.mP6Ac7VkhAd6DuIbJSeVMWbgB7mQF85Ra3OFA4bmfIuNsrMOsVijSV8y2w

Published financial data: ORIX CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	2,184B	2,316B	2,433B	2,532B	2,836B
Gain (Loss) on Sale of Investment, Total (Rev)	56.6B	32.94B	33.78B	16.06B	140B
Interest And Invest. Income (Rev)	261B	101B	114B	121B	134B
Other Revenues, Total	18.9B	216B	234B	205B	220B
Total Revenues	2,520B	2,666B	2,814B	2,875B	3,331B
Cost of Goods Sold, Total	1,575B	1,652B	1,640B	1,674B	1,892B
Gross Profit	946B	1,014B	1,174B	1,201B	1,439B
Selling General & Admin Expenses, Total	523B	559B	628B	646B	712B
Other Operating Expenses	-5.44B	11.75B	-5.7B	9.36B	6.39B
Other Operating Expenses, Total	517B	571B	622B	655B	718B
Operating Income	428B	443B	552B	545B	720B
Interest Expense, Total	-68.25B	-128B	-188B	-169B	-194B
Net Interest Expenses	-68.25B	-128B	-188B	-169B	-194B
Income (Loss) On Equity Invest.	15.01B	25.09B	36.77B	57.18B	124B
Currency Exchange Gains (Loss)	-3.35B	-1.96B	-1.13B	-3.52B	5.29B
Other Non Operating Income (Expenses)	4.45B	4.54B	-	-	-
EBT, Excl. Unusual Items	376B	343B	400B	430B	656B
Impairment of Goodwill	-562M	-	-	-	-
Gain (Loss) On Sale Of Investments	-751M	-803M	-315M	-554M	-1.66B
Gain (Loss) On Sale Of Assets	188B	26.92B	72.49B	87.7B	111B
Asset Writedown	-57.66B	-2.81B	-1.72B	-40.23B	-73.96B
Other Unusual Items	-	1.17B	-	3.75B	-
EBT, Incl. Unusual Items	505B	367B	470B	480B	691B
Income Tax Expense	187B	87.5B	131B	129B	233B
Earnings From Continuing Operations	318B	280B	339B	352B	458B
Net Income to Company	318B	280B	339B	352B	458B
Minority Interest	-5.48B	-6.59B	7.54B	-5M	-11.06B
Net Income - (IS)	312B	273B	346B	352B	447B
Preferred Dividend and Other Adjustments	-	-	7M	35M	96M
Net Income to Common Incl Extra Items	312B	273B	346B	352B	447B
Net Income to Common Excl. Extra Items	312B	273B	346B	352B	447B
Per Share Items
Net EPS - Basic	259.37	231.35	298.55	307.74	400.27
Basic EPS - Continuing Operations	259.37	231.35	298.55	307.74	400.27
Basic Weighted Average Shares Outstanding	1.2B	1.18B	1.16B	1.14B	1.12B
Net EPS - Diluted	259.07	231.04	298.05	307.16	399.4
Diluted EPS - Continuing Operations	259.07	231.04	298.05	307.16	399.4
Diluted Weighted Average Shares Outstanding	1.2B	1.18B	1.16B	1.14B	1.12B
Normalized Basic EPS	190.76	175.87	221.89	235.11	356.96
Normalized Diluted EPS	190.53	175.63	221.52	234.64	356.1
Dividend Per Share	85.6	85.6	98.6	120.01	156.1
Payout Ratio	31.84	38.92	28.86	38.56	38.19
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	759B	796B	916B	945B	1,125B
EBITA	460B	443B	591B	587B	762B
EBIT	428B	443B	552B	545B	720B
EBITDAR	808B	844B	966B	995B	1,170B
Total Revenues (As Reported)	2,520B	2,666B	2,814B	2,875B	3,331B
Effective Tax Rate - (Ratio)	37.09	23.83	27.96	26.81	33.71
Current Domestic Taxes	137B	30.81B	80.27B	72.23B	189B
Current Foreign Taxes	38.43B	27.49B	31.11B	33.25B	48.4B
Total Current Taxes	175B	58.3B	111B	105B	237B
Deferred Domestic Taxes	-631M	14.3B	9.05B	26.8B	153B
Deferred Foreign Taxes	12.84B	14.9B	10.95B	-3.46B	13.88B
Total Deferred Taxes	12.21B	29.2B	20B	23.35B	167B
Normalized Net Income	230B	208B	257B	269B	399B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	106M	150M	84M	67M	101M
Non-Cash Pension Expense	-4.21B	-5.01B	-4.82B	-6.07B	-3.96B
Supplemental Operating Expense Items
Advertising Expense	-	-	-	-	-
Selling and Marketing Expenses	-	-	-	-	-
Net Rental Expense, Total	49.63B	47.5B	49.66B	50.38B	44.51B
Imputed Operating Lease Interest Expense	5.31B	8.7B	11.99B	10.47B	10.31B
Imputed Operating Lease Depreciation	44.32B	38.8B	37.67B	39.91B	34.2B
Stock-Based Comp., Other (Total)	1.19B	937M	2.18B	1.78B	3.7B
Total Stock-Based Compensation	1.19B	937M	2.18B	1.78B	3.7B

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	955B	1,232B	1,033B	1,207B	1,335B
Short Term Investments	4.2B	4.37B	2.03B	1.4B	1.92B
Trading Asset Securities, Total	12.07B	55.41B	19B	17.87B	26.36B
Total Cash And Short Term Investments	971B	1,292B	1,054B	1,226B	1,363B
Accounts Receivable, Total	5,256B	5,397B	5,525B	5,662B	5,896B
Other Receivables	5.21B	4.68B	2.79B	17.13B	15.86B
Total Receivables	5,261B	5,402B	5,528B	5,679B	5,911B
Inventory	140B	169B	227B	229B	269B
Restricted Cash	137B	135B	152B	115B	116B
Other Current Assets, Total	41.8B	19.16B	53.99B	46.3B	128B
Total Current Assets	6,550B	7,017B	7,016B	7,295B	7,788B
Gross Property Plant And Equipment	1,131B	1,228B	1,315B	1,341B	1,368B
Accumulated Depreciation	-221B	-255B	-290B	-303B	-317B
Net Property Plant And Equipment	910B	973B	1,025B	1,037B	1,051B
Long-term Investments	3,643B	3,788B	4,416B	4,422B	4,483B
Goodwill	489B	628B	632B	622B	774B
Other Intangibles, Total	474B	590B	613B	602B	658B
Deferred Tax Assets Long-Term	46.06B	48.29B	66.52B	63.34B	47.13B
Other Long-Term Assets, Total	2,159B	2,222B	2,554B	2,824B	3,201B
Total Assets	14,271B	15,266B	16,322B	16,866B	18,003B
Liabilities
Accounts Payable, Total	291B	367B	363B	340B	356B
Short-term Borrowings	40.06B	44.52B	134B	88.22B	111B
Current Portion of Long-Term Debt	1,161B	1,345B	1,325B	1,332B	1,496B
Current Portion of Leases	48.57B	54B	51.47B	53.12B	56.77B
Current Income Taxes Payable	115B	25.2B	65.53B	53.15B	76.73B
Other Current Liabilities	1,212B	1,279B	1,479B	1,873B	1,962B
Total Current Liabilities	2,868B	3,115B	3,417B	3,740B	4,059B
Long-Term Debt	3,674B	4,332B	4,745B	4,865B	4,934B
Long-Term Leases	234B	234B	209B	206B	252B
Unearned Revenue Non Current	32.98B	34.34B	32.83B	40.44B	46.16B
Pension & Other Post Retirement Benefits	15.46B	16.97B	17.5B	16.94B	16.51B
Deferred Tax Liability Non Current	346B	360B	505B	526B	611B
Other Non Current Liabilities	3,729B	3,746B	3,371B	3,297B	3,461B
Total Liabilities	10,899B	11,838B	12,297B	12,691B	13,379B
Common Stock, Total	221B	221B	221B	221B	221B
Additional Paid In Capital	260B	233B	233B	234B	235B
Retained Earnings	2,909B	3,032B	3,260B	3,355B	3,503B
Treasury Stock	-113B	-121B	-130B	-61.73B	-81.47B
Comprehensive Income and Other	-16.04B	-8.38B	357B	341B	605B
Total Common Equity	3,261B	3,357B	3,941B	4,090B	4,482B
Minority Interest	110B	71.66B	83.14B	85.43B	141B
Total Equity	3,371B	3,428B	4,025B	4,175B	4,624B
Total Liabilities And Equity	14,271B	15,266B	16,322B	16,866B	18,003B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.19B	1.17B	1.15B	1.14B	1.1B
ECS Total Common Shares Outstanding	1.19B	1.17B	1.15B	1.14B	1.1B
Book Value / Share	2.73K	2.87K	3.42K	3.6K	4.08K
Tangible Book Value	2,299B	2,138B	2,697B	2,866B	3,050B
Tangible Book Value Per Share	1.93K	1.83K	2.34K	2.52K	2.78K
Total Debt	5,158B	6,010B	6,464B	6,545B	6,849B
Net Debt	4,187B	4,718B	5,411B	5,319B	5,486B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-32.41B	-40.83B	-61.86B	-72.98B	-99.42B
Debt Equivalent Oper. Leases	397B	380B	397B	403B	356B
Minority Interest, Total (Incl. Fin. Div)	110B	71.66B	83.14B	85.43B	141B
Equity Method Investments, Total	1,069B	1,092B	1,314B	1,320B	1,306B
Account Code - Inventory Valuation	8	8	8	8	8
Inventories - Work In Process, Total	62.41B	74.62B	118B	116B	141B
Inventories - Finished Goods, Total	77.15B	94.4B	109B	113B	128B
Full Time Employees	32.24K	34.74K	33.81K	33.98K	37.29K
Accumulated Allowance for Doubtful Accounts (Supple)	70.37B	68.31B	61.24B	58.26B	81.59B

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	312B	273B	346B	352B	447B
Depreciation & Amortization - CF	298B	353B	325B	358B	363B
Amortization of Goodwill and Intangible Assets - (CF)	32.24B	-	39.21B	41.4B	41.4B
Depreciation & Amortization, Total	330B	353B	364B	400B	405B
(Gain) Loss From Sale Of Asset	-228B	-83.85B	-126B	-164B	-181B
(Gain) Loss on Sale of Investments - (CF)	-21.59B	-7.92B	-3.63B	7.33B	985M
Asset Writedown & Restructuring Costs	35.67B	2.3B	1.72B	25.93B	16.24B
Provision for Credit Losses	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-13.75B	-24.02B	-36.77B	-57.18B	-124B
Provision and Write-off of Bad Debts	3.94B	7.76B	20.97B	18.72B	34.02B
Other Operating Activities, Total	371B	404B	448B	447B	391B
Change in Trading Asset Securities	68.42B	31.86B	-8.04B	28.49B	-6.56B
Change In Accounts Receivable	3.56B	12.95B	5.24B	-2.64B	4.56B
Change In Inventories	-7.05B	-17.53B	-58.13B	-9.84B	-39.82B
Change In Accounts Payable	14.94B	-12.17B	-4.43B	-3.91B	1.06B
Change In Income Taxes	92.03B	-129B	108B	-9.23B	25.87B
Change in Other Net Operating Assets	141B	102B	186B	268B	396B
Cash from Operations	1,103B	913B	1,243B	1,300B	1,370B
Capital Expenditure	-917B	-1,080B	-1,201B	-1,358B	-1,332B
Sale of Property, Plant, and Equipment	147B	233B	263B	374B	352B
Cash Acquisitions	-87.58B	-207B	-42.49B	-89.87B	-129B
Divestitures	253B	19.99B	140B	111B	39.7B
Investment in Marketable and Equity Securities, Total	-206B	-122B	-471B	-168B	108B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-19.94B	51.17B	-73.15B	-204B	-141B
Other Investing Activities, Total	22.12B	5.72B	12.54B	24.97B	-12.04B
Cash from Investing	-809B	-1,098B	-1,373B	-1,310B	-1,115B
Short Term Debt Issued, Total	96.38B	20.41B	10.75B	-	55.43B
Long-Term Debt Issued, Total	950B	1,826B	1,219B	1,600B	1,211B
Total Debt Issued	1,047B	1,846B	1,230B	1,600B	1,266B
Short Term Debt Repaid, Total	-	-	-	-98.62B	-
Long-Term Debt Repaid, Total	-1,168B	-1,159B	-1,178B	-1,368B	-1,273B
Total Debt Repaid	-1,168B	-1,159B	-1,178B	-1,467B	-1,273B
Repurchase of Common Stock	-50B	-52.07B	-50B	-53.52B	-150B
Common Dividends Paid	-99.4B	-106B	-99.9B	-136B	-171B
Common & Preferred Stock Dividends Paid	-99.4B	-106B	-99.9B	-136B	-171B
Other Financing Activities, Total	-35.74B	-90.86B	12.61B	206B	167B
Cash from Financing	-307B	438B	-85.48B	149B	-161B
Foreign Exchange Rate Adjustments	24.33B	22.18B	33.28B	-3.14B	34.76B
Net Change in Cash	12.24B	275B	-182B	137B	129B
Supplemental Items
Cash Interest Paid	65.96B	118B	183B	168B	189B
Cash Income Tax Paid (Refund)	83.03B	187B	3.51B	113B	-
Levered Free Cash Flow	656B	492B	660B	931B	999B
Unlevered Free Cash Flow	699B	572B	778B	1,037B	1,120B
Change In Net Working Capital	-1,017B	-1,021B	-1,267B	-1,652B	-1,594B
Net Debt Issued / Repaid	-121B	688B	51.82B	133B	-6.39B

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	1.92	1.87	2.18	2.05	2.58
Return on Total Capital	3.21	3.08	3.43	3.21	4.06
Return On Equity %	9.81	8.23	8.86	8.58	10.42
Return on Common Equity	9.92	8.25	9.25	8.76	10.43
Margin Analysis
Gross Profit Margin %	37.52	38.03	41.72	41.76	43.19
SG&A Margin	20.74	20.98	22.3	22.47	21.37
EBITDA Margin %	30.1	29.86	32.56	32.86	33.78
EBITA Margin %	18.27	16.61	21.01	20.4	22.87
EBIT Margin %	16.99	16.61	19.62	18.96	21.63
Income From Continuing Operations Margin %	12.6	10.49	12.03	12.23	13.76
Net Income Margin %	12.38	10.24	12.3	12.23	13.43
Net Avail. For Common Margin %	12.38	10.24	12.3	12.23	13.43
Normalized Net Income Margin	9.11	7.79	9.14	9.34	11.97
Levered Free Cash Flow Margin	26.04	18.46	23.46	32.39	29.99
Unlevered Free Cash Flow Margin	27.73	21.46	27.64	36.06	33.63
Asset Turnover
Asset Turnover	0.18	0.18	0.18	0.17	0.19
Fixed Assets Turnover	2.86	2.83	2.82	2.79	3.19
Receivables Turnover (Average Receivables)	0.43	0.43	0.44	0.45	0.49
Inventory Turnover (Average Inventory)	11.18	10.71	8.28	7.33	7.59
Short Term Liquidity
Current Ratio	2.28	2.25	2.05	1.95	1.92
Quick Ratio	2.17	2.15	1.93	1.85	1.79
Operating Cash Flow to Current Liabilities	0.38	0.29	0.36	0.35	0.34
Days Sales Outstanding (Average Receivables)	857.73	839.32	823.44	806.27	743.64
Days Outstanding Inventory (Average Inventory)	32.65	34.08	44.22	49.77	48.07
Average Days Payable Outstanding	64.09	71.43	78.57	76.47	65.72
Cash Conversion Cycle (Average Days)	826.29	801.97	789.09	779.57	725.99
Long Term Solvency
Total Debt/Equity	152.99	175.3	160.62	156.76	148.12
Total Debt / Total Capital	60.47	63.68	61.63	61.05	59.7
LT Debt/Equity	115.93	133.2	123.1	121.47	112.15
Long-Term Debt / Total Capital	45.83	48.38	47.23	47.31	45.2
Total Liabilities / Total Assets	76.38	77.54	75.34	75.25	74.32
EBIT / Interest Expense	6.27	3.46	2.93	3.23	3.72
EBITDA / Interest Expense	11.84	6.6	5.13	5.89	6.03
(EBITDA - Capex) / Interest Expense	-1.6	-1.85	-1.25	-2.15	-0.84
Total Debt / EBITDA	6.38	7.12	6.69	6.58	5.85
Net Debt / EBITDA	5.18	5.59	5.6	5.35	4.69
Total Debt / (EBITDA - Capex)	-47.28	-25.43	-27.53	-18.05	-42.1
Net Debt / (EBITDA - Capex)	-38.38	-19.97	-23.04	-14.67	-33.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.93	5.79	5.66	2.15	15.86
Gross Profit, 1 Yr. Growth %	16.39	7.24	12.83	2.26	19.83
EBITDA, 1 Yr. Growth %	15.75	4.97	13.19	3.09	19.12
EBITA, 1 Yr. Growth %	25.08	3.42	17.43	-0.81	29.89
EBIT, 1 Yr. Growth %	26.18	3.42	17.63	-1.26	32.16
Earnings From Cont. Operations, 1 Yr. Growth %	61.38	-11.95	14.03	3.85	30.34
Net Income, 1 Yr. Growth %	62.25	-12.51	19.22	1.59	27.2
Normalized Net Income, 1 Yr. Growth %	39.17	-9.57	17.23	4.42	48.46
Diluted EPS Before Extra, 1 Yr. Growth %	66.72	-10.82	21.33	3.06	30.03
Accounts Receivable, 1 Yr. Growth %	4.9	2.69	1.87	2.47	4.13
Inventory, 1 Yr. Growth %	-1.82	21.11	34.52	0.82	17.43
Net Property, Plant and Equip., 1 Yr. Growth %	6.74	6.93	5.38	1.16	1.34
Total Assets, 1 Yr. Growth %	5.22	6.98	6.75	3.33	6.74
Tangible Book Value, 1 Yr. Growth %	12.47	-6.97	15.98	6.27	6.43
Common Equity, 1 Yr. Growth %	7.69	2.92	11.23	3.76	9.6
Cash From Operations, 1 Yr. Growth %	0.09	-17.25	36.18	4.57	5.34
Capital Expenditures, 1 Yr. Growth %	20.59	17.75	11.18	13.06	-1.86
Levered Free Cash Flow, 1 Yr. Growth %	-521.36	-207.51	-185.45	-225.71	-212.37
Unlevered Free Cash Flow, 1 Yr. Growth %	-753.51	-237.79	-212.28	-266.41	-243
Dividend Per Share, 1 Yr. Growth %	9.74	0	15.19	21.71	30.07
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.13	7.84	5.93	3.89	8.79
Gross Profit, 2 Yr. CAGR %	4.92	11.72	11.71	7.42	10.7
EBITDA, 2 Yr. CAGR %	4.88	10.23	11	7.79	10.81
EBITA, 2 Yr. CAGR %	5.01	14.23	13.92	7.56	13.51
EBIT, 2 Yr. CAGR %	5.42	14.23	14.19	7.38	14.23
Earnings From Cont. Operations, 2 Yr. CAGR %	1.76	19.2	2.41	8.82	16.35
Net Income, 2 Yr. CAGR %	1.55	19.14	4.43	10.05	13.67
Normalized Net Income, 2 Yr. CAGR %	3.01	12.18	5.81	10.1	24.51
Diluted EPS Before Extra, 2 Yr. CAGR %	4.52	21.94	6.37	11.82	15.76
Accounts Receivable, 2 Yr. CAGR %	1.45	3.79	2.53	2.17	3.3
Inventory, 2 Yr. CAGR %	5.24	9.04	27.64	16.46	8.81
Net Property, Plant and Equip., 2 Yr. CAGR %	1.23	6.84	6.15	3.25	1.25
Total Assets, 2 Yr. CAGR %	4.5	6.09	6.95	5.03	5.02
Tangible Book Value, 2 Yr. CAGR %	4.93	2.29	8.32	11.02	6.35
Common Equity, 2 Yr. CAGR %	4.38	5.28	9.93	7.43	6.64
Cash From Operations, 2 Yr. CAGR %	2.88	-8.99	6.16	19.33	4.95
Capital Expenditures, 2 Yr. CAGR %	-3.88	19.16	14.42	12.12	5.34
Levered Free Cash Flow, 2 Yr. CAGR %	-18.98	77.78	18.41	9.92	16.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-13.67	131.3	34.78	22.51	34.08
Dividend Per Share, 2 Yr. CAGR %	6.13	4.76	7.33	18.41	25.82
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.28	5.35	7.07	4.65	7.74
Gross Profit, 3 Yr. CAGR %	2.54	5.69	13.06	8.47	11.4
EBITDA, 3 Yr. CAGR %	1.92	4.91	11.82	8.3	11.44
EBITA, 3 Yr. CAGR %	0.57	1.98	20.33	8.78	14.54
EBIT, 3 Yr. CAGR %	0.57	4.75	17.61	8.79	15.07
Earnings From Cont. Operations, 3 Yr. CAGR %	-0.97	-3.03	19.82	2.89	15.57
Net Income, 3 Yr. CAGR %	-1.21	-3.38	21.63	3.48	15.49
Normalized Net Income, 3 Yr. CAGR %	0.53	-1.37	15.97	5.34	21.64
Diluted EPS Before Extra, 3 Yr. CAGR %	0.83	-0.87	24.25	5.25	17.59
Accounts Receivable, 3 Yr. CAGR %	3.87	1.86	3.32	2.51	2.82
Inventory, 3 Yr. CAGR %	6.45	10.28	16.95	17.99	16.78
Net Property, Plant and Equip., 3 Yr. CAGR %	18.27	3.1	6.35	4.46	2.61
Total Assets, 3 Yr. CAGR %	5.44	5.32	6.37	5.73	5.6
Tangible Book Value, 3 Yr. CAGR %	4.61	0.81	9.68	7.63	9.47
Common Equity, 3 Yr. CAGR %	4.03	3.89	9.18	7.84	8.15
Cash From Operations, 3 Yr. CAGR %	23.37	-4.32	4.09	5.62	14.47
Capital Expenditures, 3 Yr. CAGR %	-4.71	2.84	16.44	13.96	7.25
Levered Free Cash Flow, 3 Yr. CAGR %	-11.09	-21.03	61.85	25.51	9.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-7.43	-15.18	93.76	34.27	17.48
Dividend Per Share, 3 Yr. CAGR %	4.04	4.04	8.13	11.92	22.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-1.21	-1.41	3.01	4.74	7.76
Gross Profit, 5 Yr. CAGR %	1.98	2.94	6.01	6.93	12.11
EBITDA, 5 Yr. CAGR %	2.33	2.75	5.04	6.5	11.42
EBITA, 5 Yr. CAGR %	0.53	-0.15	5.49	7.03	17.55
EBIT, 5 Yr. CAGR %	0.28	1.29	5.57	7.18	16.25
Earnings From Cont. Operations, 5 Yr. CAGR %	2.49	-2.75	0.7	2.77	18.42
Net Income, 5 Yr. CAGR %	2.7	-2.7	1.35	3.04	18.38
Normalized Net Income, 5 Yr. CAGR %	0.27	-2.64	2.63	4.42	19.31
Diluted EPS Before Extra, 5 Yr. CAGR %	4.42	-1.1	3.36	5.31	20.78
Accounts Receivable, 5 Yr. CAGR %	4.26	4.7	3.33	2.08	3.31
Inventory, 5 Yr. CAGR %	3.44	8.77	14.47	12.71	13.62
Net Property, Plant and Equip., 5 Yr. CAGR %	12.29	12.18	13.27	3.16	4.28
Total Assets, 5 Yr. CAGR %	4.91	5.97	6.04	5.24	5.83
Tangible Book Value, 5 Yr. CAGR %	5.57	2.99	6.08	6.54	8.34
Common Equity, 5 Yr. CAGR %	5.4	4.59	6.35	6.44	8.16
Cash From Operations, 5 Yr. CAGR %	13.58	9.93	16.17	4.52	4.44
Capital Expenditures, 5 Yr. CAGR %	-1.51	0.54	2.52	6.46	11.86
Levered Free Cash Flow, 5 Yr. CAGR %	0.35	-4.64	-6.69	-1.41	45.02
Unlevered Free Cash Flow, 5 Yr. CAGR %	3.11	-0.18	-2.46	2.03	59.96
Dividend Per Share, 5 Yr. CAGR %	10.38	5.34	5.34	9.57	14.88